Executive Summary
A new structural long position has been identified in UnitedHealth Group (UNH) as it tests key higher-timeframe demand nodes. This campaign leverages a clear risk-defined entry window to capture a longer-term value expansion, maintaining an asymmetry favoring buyers.
Technical Context & Entry Logic
The position was filled at $380.44 during an efficient test of key technical support shelves. This level represents a critical consolidation floor where institutional responsive buying has historically materialized. By initiating exposure at this node, we position the trade directly at the lower boundary of its higher-timeframe auction range, minimizing initial capital exposure relative to our ultimate target.
The primary objective of this campaign is to ride the structural trend back toward major overhead supply extensions. As value acceptance migrates upward with the new monthly profile reset, the path of least resistance favors a steady expansion toward historical macro ceilings.
Strategic Risk Parameters
To maintain strict risk alignment and capital preservation, the trade is bounded by the following mechanical invalidation nodes:
- Entry Execution: $380.44
- Protective Stop-Loss: $355.00
- Macro Technical Target: $600.00
Risk-to-Reward Assessment
- Total Risk: $25.44 per share (Distance from entry to protective floor)
- Total Upside Potential: $219.56 per share (Distance from entry to macro target)
- Risk/Reward Profile: Approximately 1:8.6
The stop-loss is anchored strictly below the $355.00 psychological and structural shelf. A clean daily close below this line invalidates our technical thesis, signaling that sellers have seized control of the higher-timeframe auction and that value is migrating lower. If this boundary is violated, the trade will be systematically closed to protect fund equity.
Required Footnote Disclaimers
Regulatory Compliance Notice: Market Profile Research is an independent publisher of general-interest financial information and technical market commentary. We are not registered investment advisors, financial planners, or broker-dealers with the SEC or any state regulatory body. This commentary does not constitute personalized investment advice, financial planning, or an endorsement or solicitation to buy or sell securities. All content is prepared strictly for educational, informational, and general research purposes under the publisher's exemption.
Risk Disclosure: The market parameters, execution prices, and protective stops discussed represent the internal research observations and proprietary tracking models of a private fund. Trading equities involves a high degree of structural risk, including the potential loss of principal capital. Past performance, asset correlation models, and historical balance zones do not guarantee future results. Subscribers are entirely responsible for their own independent financial and risk management decisions.